Xing Wen – Trademark Portfolio
Entity Type: 01
Xing Wen owns a portfolio of 20 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as OVEFINE, SIXWOER, and FREEBLUE. Of these, 3 are registered and 17 are pending. The portfolio spans 10 Nice Classification classes, led by Class 25 (Clothing) and Class 20 (Furniture). Headquartered in Xincheng County, Guangxi.
No. 44, North Street, Jiaren Village, Chengguan Town
Xincheng County, Guangxi 546299 , CN
Showing of trademarks Trademarks
Trademark Classifications
Xing Wen's trademark portfolio spans 10 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Games and playthings; gymnastic and sporting articles; decorations for Christmas trees
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Lace and embroidery, ribbons and braid; buttons, hooks and eyes, pins and needles
Frequently Asked Questions
How many trademarks does Xing Wen have?
Xing Wen has 20 U.S. trademarks filed with the USPTO. Of these, 3 registered, 17 pending.
What trademark classes does Xing Wen file in?
Xing Wen files trademarks across 10 Nice Classification classes. The most active classes are Class 25 (Clothing), Class 20 (Furniture), Class 34 (Smokers Articles), Class 28 (Toys & Sporting Goods), Class 18 (Leather Goods). Class 25 covers clothing, footwear, headgear.
What are Xing Wen's most well-known trademarks?
Xing Wen's registered trademark portfolio includes well-known marks such as OVEFINE, SIXWOER, and FREEBLUE. These are among 3 currently registered trademarks in the portfolio.
What is Xing Wen's trademark registration success rate?
Xing Wen has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 17 applications are pending review.